CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammationKathryn E. Beckermann, Jeffrey C. Rathmell, Rachel A. Hongo et al.|JCI Insight|2020Cited by 95
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccineKevin J. Kramer, Jonathan M. Irish, Erin M. Wilfong et al.|Nature Communications|2022Cited by 57
Computational Immune Monitoring Reveals Abnormal Double-Negative T Cells Present across Human Tumor TypesAllison R. Greenplate, Jonathan M. Irish, Daniel D. McClanahan et al.|Cancer Immunology Research|2018Cited by 42
A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agentsJan Philipp Bewersdorf, Amer M. Zeidan, Richard F. Little et al.|Annals of Hematology|2023Cited by 23
Generating Quantitative Cell Identity Labels with Marker Enrichment Modeling (MEM)Kirsten E. Diggins, Jonathan M. Irish, Jocelyn S. Gandelman et al.|Current Protocols in Cytometry|2018Cited by 23